Oragenics Announces Positive Data on Intranasal COVID-19 Vaccine Candidate
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read morePfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read moreBased on data obtained from Phase II and the Phase I studies, Abecma has received approval in Japan for the
Read moreOri Biotech, based in the United Kingdom, has secured €88 million ($100 million) in its Series B funding to help
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read morePfizer’s COVID-19 Antiviral, PAXLOVID, has been authorised for use in people over 18 with mild to moderate COVID-19 and at
Read moreVaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read moreEvusheld, a long-acting antibody (LAAB) combination from AstraZeneca, has received emergency use authorisation (EUA) by the FDA in the United
Read more